Watchlist
Loading...
US Stock MarketDetailed Quotes

TTOO T2 Biosystems

Watchlist
0.1809 -0.0215-10.62% Close 09/27 16:00 ET
0.1731-0.0078-4.31% Pre 04:19 ET
0.2180High0.1700Low74.33MVolume
Pre-Market
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About T2 Biosystems Company

T2 Biosystems, Inc. engages in the development of a proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables detection of pathogens, biomarkers, and other abnormalities in a range of unpurified patient sample types. The firm's products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

Revenue Breakdown

Business Unit:USD
12/31/2022
Stock NameRevenueRatio
Product revenue11.26M50.48%
Contribution revenue11.05M49.52%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >